Neurocrine Biosciences Inc (NASDAQ:NBIX)

101.20
BATS BZX Real-Time Price
As of 3:55pm ET
 +0.72 / +0.72%
Today’s Change
71.88
Today|||52-Week Range
109.26
+18.82%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 114.50, with a high estimate of 151.14 and a low estimate of 78.00. The median estimate represents a +13.14% increase from the last price of 101.20.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.79
Sales
$375.9M
Reporting Date
Nov 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 540.74%
 
 
 
 
 
 
Growthannually 120.43%
 
 
 
 
 
 

Sales

Growthquarterly -0.62%
 
 
 
 
 
 
Growthannually 28.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.